Rehabilitation Equipment

Rehabilitation Equipment Elastollan 1195A Injection Molding with Zhafir Zeres III 300T

As engineers designing for the Rehabilitation Equipment sector, we operate in a world of non-negotiable demands. The components we create are not just parts; they are extensions of a user's body, subjected to relentless mechanical stress, constant exposure to human sweat, and aggressive cleaning protocols. Failure isn't an option, and mediocrity can directly impact a user's quality of life. This unforgiving environment dictates a material selection process that prioritizes durability, chemical resistance, and biocompatibility. Enter a material like BASF Elastollan 1195A, a polyether-based thermoplastic polyurethane (TPU) that, on paper, seems purpose-built for the challenge. With its 95A Shore hardness, excellent tensile strength, and inherent resistance to hydrolysis and microbial attack, it’s a compelling choice for grips, bumpers, seals, and load-bearing flexible components.

However, as any seasoned process engineer knows, a material's datasheet is only half the story. The other half is written on the factory floor, and with a material as sensitive as Elastollan 1195A, the narrative can quickly turn into a horror story. This TPU is notoriously hygroscopic, acting like a sponge for atmospheric moisture. It's also highly shear-sensitive. Bring this improperly prepared material to its melt temperature in an unstable process, and you trigger a cascade of failures. Hydrolysis cleaves the polymer chains, catastrophically dropping the viscosity and molecular weight. The result? Parts with splay, internal porosity, brittleness, and a complete deviation from specified mechanical properties. These are not just cosmetic defects; they are latent structural failures waiting to happen, a risk that is simply unacceptable in a medical context. This is the core engineering problem: how do you unlock the full potential of a high-performance but difficult-to-process material? The answer lies not in compromise, but in absolute process control.

Uncompromising Compliance: ISO 13485, ISO 7176, and CE MDR Alignment

In the medical device space, manufacturing isn't just about making parts; it's about making parts within a rigorously documented and validated quality management system (QMS). Our approach to molding Elastollan 1195A is architected from the ground up to satisfy the stringent requirements of ISO 13485, ISO 7176 for wheelchairs, and the EU's CE Medical Device Regulation (MDR).

ISO 13485 & Process Validation (IQ/OQ/PQ): This standard is the bedrock of medical device manufacturing, demanding total process control and traceability. The challenge with a sensitive TPU is maintaining a validated state. A standard hydraulic injection molding machine, with its inherent temperature fluctuations and pressure variations, can easily drift out of its validated process window. Our reliance on the Zhafir Zeres III 300T all-electric press directly addresses this. Every parameter—from injection velocity and pressure to screw position and melt cushion—is controlled by a precise servo motor. This allows us to perform a rigorous Design of Experiments (DOE) to define a robust process window during Operational and Performance Qualification (OQ/PQ). More importantly, it allows us to stay in that window. The shot-to-shot repeatability of an all-electric press is an order of magnitude greater than that of a hydraulic equivalent. This means the process validation you sign off on is the process that runs for every single part, from the first to the last. Furthermore, the machine's control system provides a complete data log for every cycle, creating an unimpeachable record for your device history file (DHF) and ensuring full traceability.

ISO 7176 & Mechanical Integrity: This standard for wheelchairs contains a battery of tests for static and dynamic durability. For components like armrest pads, joystick grips, or protective bumpers molded from Elastollan 1195A, passing these tests is contingent on the part's internal structural integrity. The primary failure vector for this material is porosity caused by hydrolysis during molding. These microscopic voids become stress concentrators, initiating cracks under cyclic loading and leading to premature failure. Our factory advantage is the ability to produce non-porous, net-shape components directly from the tool. By mitigating the risk of hydrolysis through superior thermal stability and repeatable injection profiles, we ensure the molded part retains the full mechanical strength specified on the material's datasheet. The result is a component that can withstand the rigors of ISO 7176 testing and, more importantly, the demands of daily use.

CE MDR & Risk Mitigation: The CE MDR places a heavy emphasis on proactive risk management throughout the device lifecycle. For a molded component, the most significant risk is improper processing leading to a latent defect. Our choice of equipment and process is a direct risk mitigation strategy. By using a machine that inherently stabilizes the process for a sensitive material, we are designing risk out of the manufacturing stage. This allows us to state with high confidence in the technical file that the risk of material degradation during production has been minimized. Additionally, producing a non-porous part with an exceptional surface finish creates an inherent seal. This is critical for preventing the ingress of sweat, cleaning fluids, and bacteria, directly supporting the biocompatibility and safety requirements of the MDR without the need for costly and fallible secondary sealing operations.

Core Process & Material Specifications

To achieve this level of precision, we operate within a tightly controlled envelope of machine and material parameters. The Zhafir Zeres III 300T isn't just a machine; it's a precision instrument. When paired with a well-designed tool and a deep understanding of Elastollan 1195A's rheology, it enables us to deliver on the promise of net-shape, validated components. The following table outlines the key parameters that define this high-performance manufacturing cell.

Cost Dynamics and the TCO Advantage for 100-1,000 Unit Volumes

The economic sweet spot for this process is the 100 to 1,000 unit production run. This volume range is often a "valley of death" for complex molded parts—too small for the full economies of scale of a multi-cavity, lights-out operation, yet too large for prototyping methods. In this zone, per-part cost is highly sensitive to setup time, scrap rate, and secondary operations. This is where our specific factory advantage delivers a decisive reduction in Total Cost of Ownership (TCO).

The core of this advantage is our mitigation of the two primary processing demons of Elastollan 1195A: hydrolysis and shear degradation. A standard hydraulic press is a blunt instrument for such a delicate task. Its reliance on a large volume of oil as a power transmission fluid introduces thermal instability. As the oil heats and cools, the machine's response time and pressure delivery can vary, making a truly repeatable process nearly impossible.

Our Zhafir Zeres III 300T, being all-electric, sidesteps this entirely. Every movement—injection, plasticizing, clamping, ejection—is driven by a dedicated, digitally controlled servo motor. This provides unparalleled thermal stability and shot-to-shot repeatability. When molding a hygroscopic material, this stability is paramount. We can maintain a precise melt temperature, ensuring the properly-dried TPU pellets are not overheated, which would accelerate any residual moisture's hydrolytic attack. The servo-controlled injection unit allows us to profile the injection velocity with surgical precision. This isn't just about filling the part; it's about managing the shear rate the material experiences as it flows through the nozzle, runners, and gate. For a shear-sensitive material like Elastollan 1195A, inconsistent shear leads to inconsistent viscosity, resulting in flow marks, weld line weakness, and dimensional variance. By ensuring every shot experiences the exact same shear history, we preserve the material's intended rheological properties, leading to a homogenous, strong, and dimensionally perfect part.

This technical superiority translates directly into economic benefits. By consistently producing net-shape, non-porous components with an excellent surface finish, we eliminate the need for costly and labor-intensive secondary operations. There is no need for a separate step to seal the surface against bacterial ingress, as the as-molded part is already non-porous. There is no need for manual inspection and rejection of parts with splay or cosmetic blemishes. The scrap rate plummets. For a 500-unit run, reducing the scrap rate from a typical 10-15% for a difficult material down to 1-2% represents a significant saving in both material and machine time. The ability to achieve this in a single, validated step means your parts move from the press to assembly faster, reducing lead times and work-in-progress inventory. This is how the MechanoFab approach leverages superior equipment and deep process knowledge to deliver dimensionally perfect, load-bearing parts that meet the highest medical standards, ultimately lowering your TCO and accelerating your time to market.

Conclusion: From Process Control to Patient Care

Ultimately, the choice to pair a challenging material like Elastollan 1195A with a high-precision machine like the Zhafir Zeres III 300T is a commitment to excellence. It's an understanding that for rehabilitation equipment, the quality of a single component can have a profound impact. By mastering the process, we eliminate manufacturing variables and deliver parts that are not only compliant but superior in their mechanical integrity and finish. This is engineering-driven manufacturing, designed to mitigate risk and deliver certainty.